95 related articles for article (PubMed ID: 21704421)
41. Evidence of multiple infectious agents in mycosis fungoides lesions.
Bonin S; Tothova SM; Barbazza R; Brunetti D; Stanta G; Trevisan G
Exp Mol Pathol; 2010 Aug; 89(1):46-50. PubMed ID: 20470773
[TBL] [Abstract][Full Text] [Related]
42. Human herpesvirus-8 is not associated with angiolymphoid hyperplasia with eosinophilia.
Bhattacharjee P; Hui P; McNiff J
J Cutan Pathol; 2004 Oct; 31(9):612-5. PubMed ID: 15330993
[TBL] [Abstract][Full Text] [Related]
43. Phenotypic characterization of lymphocyte subsets in mycosis fungoides. Comparison with large plaque parapsoriasis and benign chronic dermatoses.
Ralfkiaer E; Wantzin GL; Mason DY; Hou-Jensen K; Stein H; Thomsen K
Am J Clin Pathol; 1985 Nov; 84(5):610-9. PubMed ID: 4061384
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of T-cell receptor gene rearrangements in patients with recurrent patch/plaque (T2) CTCL (mycosis fungoides).
Thayu M; Tallini G; Glusac EJ; Kacinski BM; Wilson LD
Yale J Biol Med; 1999; 72(6):365-75. PubMed ID: 11138932
[TBL] [Abstract][Full Text] [Related]
45. The nature of mycosis fungoides.
Lawrence CM; Marks JM; Burridge A; Moss C; Ive FA; McGibbon D; Parker S; Coburn P; Shuster S
Q J Med; 1986 Mar; 58(227):281-93. PubMed ID: 3737871
[TBL] [Abstract][Full Text] [Related]
46. Human herpesvirus 6 in human immunodeficiency virus-infected individuals: association with early histologic phases of lymphadenopathy syndrome but not with malignant lymphoproliferative disorders.
Dolcetti R; Di Luca D; Carbone A; Mirandola P; De Vita S; Vaccher E; Sighinolfi L; Gloghini A; Tirelli U; Cassai E; Boiocchi M
J Med Virol; 1996 Apr; 48(4):344-53. PubMed ID: 8699167
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
48. Examination of mycosis fungoides for the presence of Epstein-Barr virus and human herpesvirus-6 by polymerase chain reaction.
Erkek E; Sahin S; Atakan N; Kocagöz T; Olut A; Gököz A
J Eur Acad Dermatol Venereol; 2001 Sep; 15(5):422-6. PubMed ID: 11763382
[TBL] [Abstract][Full Text] [Related]
49. Subsequent cancers, mortality, and causes of death in patients with mycosis fungoides and parapsoriasis: a Danish nationwide, population-based cohort study.
Lindahl LM; Fenger-Grøn M; Iversen L
J Am Acad Dermatol; 2014 Sep; 71(3):529-35. PubMed ID: 24836079
[TBL] [Abstract][Full Text] [Related]
50. [Current possibilities of the differential diagnosis of plaque parapsoriasis and the early stages of mycosis fungoides].
Olisova OY; Grekova EV; Varshavsky VA; Gorenkova LG; Alekseeva EA; Zaletaev DV; Sydikov AA
Arkh Patol; 2019; 81(1):9-17. PubMed ID: 30830099
[TBL] [Abstract][Full Text] [Related]
51. Identification of herpes simplex virus DNA and lack of human herpesvirus-8 DNA in mycosis fungoides.
Erkek E; Sentürk N; Dinçer I; Olut AI; Kocagöz T; Bükülmez G; Sahin S
Acta Derm Venereol; 2002; 82(3):214-6. PubMed ID: 12353718
[No Abstract] [Full Text] [Related]
52. Cell adhesion molecule 1 expression in mycosis fungoides versus parapsoriasis versus inflammatory dermatosis: an immunohistochemical comparative study.
Neinaa YME; El-Maadawy IH; Atteia IA; Mohamed DAE
Arch Dermatol Res; 2023 Oct; 315(8):2403-2411. PubMed ID: 36943432
[TBL] [Abstract][Full Text] [Related]
53. Large plaque parapsoriasis: clinical and genotypic correlations.
Simon M; Flaig MJ; Kind P; Sander CA; Kaudewitz P
J Cutan Pathol; 2000 Feb; 27(2):57-60. PubMed ID: 10678699
[TBL] [Abstract][Full Text] [Related]
54. Early mycosis fungoides: molecular analysis for its diagnosis and the absence of p53 gene mutations in cases with progression.
Kapur S; Menke MA; Tiemann M; Schubert C; Parwaresch R
J Dermatol Sci; 2001 May; 26(1):36-45. PubMed ID: 11323219
[TBL] [Abstract][Full Text] [Related]
55. Cutavirus Infection in Large Plaque Parapsoriasis, a Premalignant Condition of Mycosis Fungoides.
Hashida Y; Nakajima K; Higuchi T; Ujihara T; Nakai K; Daibata M
J Infect Dis; 2023 Nov; ():. PubMed ID: 37995315
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of low-dose ultraviolet a-1 phototherapy for parapsoriasis/early-stage mycosis fungoides.
Aydogan K; Yazici S; Balaban Adim S; Tilki Gunay I; Budak F; Saricaoglu H; Tunali S; Bulbul Baskan E
Photochem Photobiol; 2014; 90(4):873-7. PubMed ID: 24502428
[TBL] [Abstract][Full Text] [Related]
57. Characterization of the lymphoproliferative diseases in the skin by DNA analysis.
Nakajima N; Tanaka T; Miyachi Y; Imamura S; Kakizuka A
J Dermatol; 1991 Nov; 18(11):627-34. PubMed ID: 1800528
[TBL] [Abstract][Full Text] [Related]
58. Lymphocyte function and chromosome aberrations in patients with early mycosis fungoides and parapsoriasis en plaques.
Clemmensen OJ; Bendtzen K; Andersen V; Wulf HC; Niebuhr E; Thomsen K; Bendixen G
J Invest Dermatol; 1983 Oct; 81(4):308-13. PubMed ID: 6352825
[TBL] [Abstract][Full Text] [Related]
59. Parapsoriasis-A Diagnosis with an Identity Crisis: A Narrative Review.
Chairatchaneeboon M; Thanomkitti K; Kim EJ
Dermatol Ther (Heidelb); 2022 May; 12(5):1091-1102. PubMed ID: 35426607
[TBL] [Abstract][Full Text] [Related]
60. Biophysical and ultrasonographic changes in early patch/plaque stage of mycosis fungoides, compared with uninvolved skin.
Yazdanparast T; Yazdani K; Ahmad Nasrollahi S; Izadi Firouzabadi L; Humbert P; Khatami A; Kassir M; Firooz A
Skin Res Technol; 2021 Nov; 27(6):1029-1034. PubMed ID: 33974716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
